Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg, 235:6 (2002), 863–71., , , et al.
Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg, 93:4 (2006), 457–64., , , , and
Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer. World J Surg, 29:3 (2005), 363–8., , , et al.
Incurable colorectal carcinoma: the role of surgical palliation. Am Surg, 70:5 (2004), 433–7., , and
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg, 235:6 (2002), 759–66., , , et al.
Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol, 13:5 (2006), 668–76., , , et al.
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intra-peritoneal chemotherapy. Cancer, 92:1 (2001), 71–6., , , et al.
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ, 324:7341 (2002), 813., , , and
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol, 22:8 (2004), 1420–9., , , et al.
Venous spread in rectal cancer. Proc R Soc Med, 34 (1941), 571–3. and
The significance of vein invasion by cancer of the rectum and sigmoid: a microscopic study of 210 cases. Cancer, 2 (1949), 429–37.
Venous permeation of colorectal carcinoma. Jpn J Surg, 10:4 (1980), 284–9., , and
The clinical significance of invasion of veins in cancer of the rectum. Br J Surg, 67:6 (1980), 439–42., , , et al.
Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum, 34:9 (1991), 798–804., , and
Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg, 141:1 (1981), 15–17., , , et al.
Ovarian metastasis from colorectal cancer. Dis Colon Rectum, 29:11 (1986), 767–71., , and
Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer, 5:2 (2005), 108–13., , , , and
PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging, 33:2 (2006), 134–9., , , et al.
Resection of combined or sequential lung and liver metastases of colorectal cancer: indication for everyone?]. Zentralbl Chir, 130:6 (2005), 539–43., , , et al. [
Lung resection for colorectal metastases. 10-year results. Arch Surg, 127:12 (1992), 1403–6., , , et al.
Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum, 45:4 (2002), 468–73, discussion 473–5., , , et al.
Computed tomography of Krukenberg tumors. AJR Am J Roentgenol, 145:2 (1985), 285–8. and
Krukenberg tumors: CT features and growth characteristics. South Med J, 82:10 (1989), 1215–19., , and
CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors. J Comput Assist Tomogr, 20:3 (1996), 393–8., , , , and
Ovarian metastasis in patients with colorectal carcinoma. Acta Med Okayama, 48:1 (1994), 43–6., , , et al.
Simultaneous bilateral oophorectomy does not improve prognosis of post-menopausal women undergoing colorectal resection for cancer. Dis Colon Rectum, 40:11 (1997), 1299–302., , , et al.
Management of post-operative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. Hepatogastroenterology, 51:59 (2004), 1350–3., , , et al.
The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer. Colorectal Dis, 7:3 (2005), 214–17., , and
Anatomic CT demonstration of the peritoneal spaces, ligaments, and mesenteries: normal and pathologic processes. Radiographics, 15:4 (1995), 755–70., , and
Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol, 54:9 (1999), 563–74. and
The peritoneal ligaments and mesenteries: pathways of intra-abdominal spread of disease. Radiology, 163:3 (1987), 593–604., , , and
Cytoreductive surgery combined with peri-operative intra-peritoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol, 22:16 (2004), 3284–92., , , et al.
Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg, 20:5 (1996), 585–91, discussion 592., , , , and
Treatment of colorectal liver metastases. Br J Surg, 86:2 (1999), 158–69. and
Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg, 84:7 (1997), 977–80., , , et al.
Liver resection for colorectal metastases. J Clin Oncol, 15:3 (1997), 938–46., , , et al.
Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg, 135:8 (2000), 933–8., , , et al.
Intra-operative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg, 66:7 (2000), 611–15., , and
Repeat resections of primary hepatic malignancies. Cancer Treat Res, 69 (1994), 53–6. and
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery, 131:4 (2002), 433–42., , , , and
Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Ann R Coll Surg Engl, 83:2 (2001), 85–8., , , et al.
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol, 8:4 (2001), 347–53., , , et al.
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol, 10:6 (1999), 663–9., , , et al.
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg, 230:3 (1999), 309–18, discussion 318–21., , , , and
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg, 188:1 (1999), 33–42., , , et al.
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg, 233:3 (2001), 293–9., , , , and
Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg, 8:2 (2004), 150–7, discussion 157–8., , , , and
Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum, 45:4 (2002), 476–84., , , et al.
Intra-operative uses of contrast-enhanced ultrasound. Eur Radiol, 14:suppl. 8 (2004), P87–95. and
Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer, 59:9 (1987), 1547–53., , , , and
Hepatic metastases from colorectal cancer: pre-operative detection and assessment of resectability with helical CT. Radiology, 218:1 (2001), 55–60., , , et al.
Breath-hold three-dimensional CT of the liver with multi-detector row helical CT. Radiology, 219:1 (2001), 75–9., , and
Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol, 56:3 (2001), 235–42., , , et al.
Do arterial phase helical CT images improve detection or characterization of colorectal liver metastases?J Comput Assist Tomogr, 21:3 (1997), 391–7., , , et al.
Small hypoattenuating lesions in the liver on single-phase helical CT in pre-operative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr, 26:5 (2002), 718–24., , , et al.
Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging, 13:3 (2001), 397–401., , , and
Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology, 217:1 (2000), 152–8., , , et al.
Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. AJR Am J Roentgenol, 188:2 (2007), W154–61., , , , and
Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn Reson Imaging, 8:3 (1990), 267–76., , , and
Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the pre-operative assessment of liver resectability. Ann Surg Oncol, 8:7 (2001), 573–9., , , and
Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology, 224:3 (2002), 748–56., , , , and
Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg, 233:3 (2001), 310–19., , , et al.